Frontiers in Cardiovascular Medicine

NOVEMBER 25, 2024

Laboratory results revealed a rapidly progressing disseminated intravascular coagulation (“DIC”) and a clinically asymptomatic COVID-19 infection. The patient died 38 h after admission due to a second-stage subarachnoid hemorrhage associated with progressive DIC.

Hemorrhage 59

Hemorrhage COVID-19 Laboratory Stroke 59

Journal of the American Heart Association

JANUARY 31, 2024

BackgroundPatients with ischemic stroke and concomitant COVID‐19 infection have worse outcomes than those without this infection, but the impact of COVID‐19 on hemorrhagic stroke remains unclear. We aimed to assess if COVID‐19 worsens outcomes in intracerebral hemorrhage (ICH).Methods

COVID-19 40

COVID-19 Hemorrhage Outcomes Nursing 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP34-ATP34, February 1, 2024. Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. revealing an increase from pre-COVID 3.3

COVID-19 40

COVID-19 Hemorrhage Outcomes Inpatient 40

Stroke Journal

DECEMBER 21, 2023

Stroke, Volume 55, Issue 1 , Page 78-88, January 1, 2024. BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. 1.51]; S-COVID, 2.10 [95% CI, 1.75–2.53]). versus 85.6%;P<0.001),

COVID-19 40

COVID-19 Outcomes Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A58-A58, February 1, 2024. Multivariable logistic models were used to evaluate the differences in mortality between patients admitted from April to December 2020, with and without COVID-19, and those admitted during a similar period in 2019. 2.51; SAH: 2.76, 1.68-4.54), 4.16; SAH: 5.77, 1.57-21.17).

COVID-19 40

COVID-19 Hemorrhage Public Health Inpatient 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP180-ATP180, February 1, 2024. Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%.

COVID-19 40

COVID-19 Thrombosis Outcomes Hospital 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThe coronavirus disease 2019 (COVID‐19) pandemic has had a global impact on healthcare systems. There is limited data on the influence of COVID‐19 on treatment and outcomes in patients with intracranial aneurysms.

COVID-19 40

COVID-19 Aneurysm Outcomes Inpatient 40